Researchers evaluated the impact of COVID-19 on the mental health of secondary school children in the UK.
EMA accepts Alvotech and Advanz Pharma’s AVT05 MAA
This application marks the first global MAA filing for a biosimilar candidate to Simponi for treating chronic inflammatory conditions. Credit: BlurryMe/Shutterstock. The European Medicines Agency